Basal Insulin Inadequacy versus Failure - Using Appropriate Terminology

Area of Science:

• Endocrinology
• Pharmacology
• Diabetes Management

Background:

• Current terminology for basal insulin therapy, specifically 'basal insulin failure', is analyzed.
• The need for more precise language in describing treatment responses to basal insulin is identified.

Discussion:

• 'Basal insulin inadequacy' is proposed as a more accurate descriptor than 'basal insulin failure'.
• This terminology shift addresses situations where patients do not achieve glycemic targets with basal insulin alone.
• Pharmacokinetic and pharmacodynamic variations among different basal insulin products are discussed.

Key Insights:

• The proposed term 'basal insulin inadequacy' better reflects the nuances of patient response to basal insulin therapy.
• A drug-specific definition for insulin inadequacy is recommended over generic class-based labeling.
• Understanding the specific properties of basal insulin preparations is crucial for accurate assessment.

Outlook:

• Adoption of 'basal insulin inadequacy' may improve clinical communication and patient management strategies.
• Further research into drug-specific definitions for basal insulin response is warranted.
• This refined terminology could enhance the precision of diabetes treatment guidelines.